Asha Jacob is a biological researcher interested in identifying novel mediators and their antagonists to establish therapeutic interventions to treat inflammatory diseases.  She co-authored a seminal Nature Medicine article reporting the discovery of extracellular cold-inducible RNA-binding protein (eCIRP) as a novel mediator in hemorrhagic shock and sepsis.  She has investigated the role of novel mediators in inflammatory conditions including alcohol and radiation pathologies, hemorrhagic shock and ischemia reperfusion injury. These contributions to research in biomedical sciences have led to the publication of >65 peer-reviewed journal articles. She is an Associate Professor at the Center for Immunology and Inflammation, Feinstein Institutes for Medical Research, New York, USA. She also holds a combined academic appointment as Associate Professor in the Department of Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell and the Elmezzi Graduate School of Molecular Medicine at Northwell Health. She is an active member of the Shock Society and a prior member of various societies including the American Diabetes Association. She served as a principal investigator on a National Institutes of Health grant to study the role of eCIRP in alcohol-induced neurosuppression and currently serves as a MPI on a NIH grant to study ghrelin as a countermeasure for radiation injury and as co-investigator on a number of NIH studies including hemorrhagic shock.